...
首页> 外文期刊>Current Pharmaceutical Biotechnology >Deep Tissue Optical and Optoacoustic Molecular Imaging Technologies for Pre-Clinical Research and Drug Discovery
【24h】

Deep Tissue Optical and Optoacoustic Molecular Imaging Technologies for Pre-Clinical Research and Drug Discovery

机译:用于临床前研究和药物发现的深层组织光学和光声分子成像技术

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

For centuries, biological discoveries were based on optical imaging, in particular microscopy but also several chromophoric assays and photographic approaches. With the recent emergence of methods appropriate for bio-marker in vivo staining, such as bioluminescence, fluorescent molecular probes and proteins, as well as nanoparticle-based targeted agents, significant attention has been shifted toward in vivo interrogations of different dynamic biological processes at the molecular level. This progress has been largely supported by the development of advanced tomographic imaging technologies suitable for obtaining volumetric visualization of bio-marker distributions in small animals at a whole-body or whole-organ scale, an imaging frontier that is not accessible by the existing tissue-sectioning microscopic techniques due to intensive light scattering beyond the depth of a few hundred microns. Major examples of such recently developed optical imaging modalities are reviewed here, including bioluminescence tomography (BLT), fluorescence molecular tomography (FMT), and optical projection tomography (OPT). The pharmaceutical imaging community has quickly appropriated itself of these novel forms of optical imaging, since they come with very compelling advantages, such as quantitative three-dimensional capabilities, direct correlation to the biological cultures, easiness and cost-effectiveness of use, and the use of safe non-ionizing radiation. Some multi-modality approaches, combining light with other imaging modalities such as X-Ray CT or MRI, giving the ability to acquire both an optical contrast reconstruction along with a hi-fidelity anatomical images, are also reviewed. A separate section is devoted to the hybrid imaging techniques based on the optoacoustic phenomenon, such as multispectral optoacoustic tomography (MSOT), which are poised to leverage the traditional contrast and specificity advantages of optical spectrum by delivering an ever powerful set of capabilities, including real-time operation and high spatial resolution, not affected by the scattering nature of biological tissues.
机译:几个世纪以来,生物学发现都是基于光学成像,特别是显微镜,但也有多种发色测定和照相方法。随着最近出现的适用于生物标志物体内染色的方法,例如生物发光,荧光分子探针和蛋白质,以及基于纳米颗粒的靶向剂,人们已将大量注意力转向了体内不同动态生物学过程的体内询问。分子水平。这项进展在很大程度上得到了先进的层析成像技术的发展的支持,该技术适用于以全身或整个器官的规模获得小动物体内生物标志物分布的体积可视化,这是现有组织无法获得的成像前沿。由于强烈的光散射超过了几百微米的深度,所以采用了切片技术。此处回顾了此类最近开发的光学成像模式的主要示例,包括生物发光层析成像(BLT),荧光分子层析成像(FMT)和光学投影层析成像(OPT)。药物影像学界已迅速将这些新颖形式的光学影像学应用起来,因为它们具有非常引人注目的优势,例如定量三维能力,与生物培养物的直接相关性,使用的简便性和成本效益以及使用方法。安全的非电离辐射。还回顾了一些多模态方法,将光与其他成像模态(例如X射线CT或MRI)相结合,从而能够同时获取光学对比度重建和高保真解剖图像。一个单独的部分专门介绍了基于光声现象的混合成像技术,例如多光谱光声层析成像(MSOT),该技术有望通过提供一整套强大的功能(包括实际的)来利用光谱的传统对比度和特异性优势。时间操作和高空间分辨率,不受生物组织的散射性质的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号